• FirefoxUpgrade to the new Firefox »
  •  Dow Up2.43% Nasdaq Up2.24%

    Sunesis Pharmaceuticals, Inc. (SNSS)

    -NasdaqCM
    2.58 Up 0.02(0.78%) Dec 18, 4:00PM EST
    |After Hours : 2.58 0.00 (0.00%) Dec 18, 4:42PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 7,956   3,754   5,000  
    Cost of Revenue -   -   -  
    Gross Profit 7,956   3,754   5,000  
    Operating Expenses
    Research Development28,891  29,185  22,563  
    Selling General and Administrative10,838  9,175  8,303  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (31,773) (34,606) (25,866)
    Income from Continuing Operations
    Total Other Income/Expenses Net92  (7,490)5,984  
    Earnings Before Interest And Taxes(31,681)(42,096)(19,882)
    Interest Expense2,917  1,855  259  
    Income Before Tax(34,598)(43,951)(20,141)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(34,598)(43,951)(20,141)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (34,598) (43,951) (20,141)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (34,598) (43,951) (20,141)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.